Jack Higgins insider trades: Immunome (IMNM) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jack reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | IMNM | ↓ Sell | 13,200 | $25.32 | $334K | Direct | Sep 15, 2026 (4d) |
| Apr 2, 2026 | IMNM | ↓ Sell | 9,438 | $21.64 | $204K | Direct | Apr 3, 2026 (1d) |
| Aug 15, 2024 | IMNM | ↓ Sell | 3,524 | $13.93 | $49K | Direct | Aug 19, 2024 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IMNM insiders
Open-market trades in the last 12 months
About Jack Higgins's insider trades
Jack Higgins is Chief Scientific Officer at Immunome (IMNM). Since Aug 15, 2024, Jack has reported no open-market purchases and 3 sales worth $588K on SEC Form 4. In the last 12 months: 2 sales ($538K).
Their filings also include gifts (4 filings), option exercises (4 filings), grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IMNM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.